financetom
Business
financetom
/
Business
/
Enfusion Shares Slip After Short-Seller Spruce Point Warns of 'Financial Restatement Risk'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enfusion Shares Slip After Short-Seller Spruce Point Warns of 'Financial Restatement Risk'
Mar 14, 2024 7:53 AM

10:37 AM EDT, 03/14/2024 (MT Newswires) -- Enfusion ( ENFN ) shares slipped 2.5% in recent Thursday trading after short-seller Spruce Point Management raised concerns about the company's "financial restatement risk."

Enfusion ( ENFN ) did not immediately respond to a request for comment by MT Newswires.

"We believe revenue is at high risk of misstatement as we find accounts that appear to have been quietly revised or do not reconcile," Spruce Point said Thursday.

The firm said it "believes that financial restatement risk is high."

Price: 9.09, Change: -0.23, Percent Change: -2.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Marzetti Raises Quarterly Dividend to $1.00 a Share; Payable Dec. 31 to Holders of Record Dec. 5
--Marzetti Raises Quarterly Dividend to $1.00 a Share; Payable Dec. 31 to Holders of Record Dec. 5
Nov 19, 2025
02:22 PM EST, 11/19/2025 (MT Newswires) -- Price: 170.35, Change: +0.13, Percent Change: +0.08 ...
Amazon Web Services, Saudi's Humain Expand Partnership to Further AI Innovation
Amazon Web Services, Saudi's Humain Expand Partnership to Further AI Innovation
Nov 19, 2025
02:23 PM EST, 11/19/2025 (MT Newswires) -- Amazon Web Services, Amazon's ( AMZN ) cloud computing platform, and Saudi Arabian artificial intelligence company Humain plan to deploy and manage up to 150,000 AI accelerators at a data center facility in Riyadh, the companies said Wednesday. The data center infrastructure will use the Nvidia (NVDA) GB300 AI infrastructure and AWS's Trainium...
BRIEF-Kitron To Buy 100% Of DeltaNordic Shares
BRIEF-Kitron To Buy 100% Of DeltaNordic Shares
Nov 19, 2025
Nov 19 (Reuters) - Kitron ASA: * KITRON ACQUIRES DELTANORDIC, STRENGTHENING ITS POSITION IN DEFENCE * KITRON ASA - TO BUY 100% OF DELTANORDIC SHARES * KITRON ASA - PURCHASE IS BASED ON AN ENTERPRISE VALUE OF SEK 1,255 MILLION (EUR 114 MILLION) ON A DEBT- AND CASH-FREE BASIS * KITRON ASA: KITRON OUTLOOK 2025 (EXCLUDING DELTANORDIC): REVENUE EUR 700-740...
Johnson & Johnson's Janssen Gets FDA Approval for Darzalex in Amyloidosis
Johnson & Johnson's Janssen Gets FDA Approval for Darzalex in Amyloidosis
Nov 19, 2025
02:21 PM EST, 11/19/2025 (MT Newswires) -- Johnson & Johnson's ( JNJ ) Janssen Biotech unit has been granted traditional approval to Darzalex Faspro with bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed light chain amyloidosis, the US Food and Drug Administration said Wednesday. The approval for Darzalex, with active ingredients daratumumab and hyaluronidase-fihj, was based on major organ deterioration progression...
Copyright 2023-2026 - www.financetom.com All Rights Reserved